Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tanne

Showing results (201-210 of 211) with videos related to

Pageof 22
Sort By:
European Stroke Journal|August 20, 2021
Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) - study protocol for a randomised controlled trialPeter Kelly, Christian Weimar, Robin Lemmens, et al.
Journal of Neuroimmunology|August 6, 2014
Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: a systematic review and meta-analysisAlejandro Bustamante, Tomás Sobrino, Dolors Giralt, et al.
The New England Journal of Medicine|February 18, 2016
Pioglitazone after Ischemic Stroke or Transient Ischemic AttackWalter N Kernan, Catherine M Viscoli, Karen L Furie, et al.
The New England Journal of Medicine|May 15, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral HemorrhageStuart J Connolly, Mukul Sharma, Alexander T Cohen, et al.
The Lancet. Neurology|December 15, 2023
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trialMukul Sharma, Carlos A Molina, Kazunori Toyoda, et al.
BMJ Open|November 16, 2019
Global Outcome Assessment Life-long after stroke in young adults initiative-the GOAL initiative: study protocol and rationale of a multicentre retrospective individual patient data meta-analysisMerel S Ekker, Mina A Jacob, Myrna M E van Dongen, et al.
Neurology|December 15, 2021
Global Differences in Risk Factors, Etiology, and Outcome of Ischemic Stroke in Young Adults-A Worldwide Meta-analysis: The GOAL InitiativeMina A Jacob, Merel S Ekker, Youssra Allach, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 25, 2026
Prediction of recurrence and functional status in young ischemic stroke patients: Comparison of machine learning and traditional statistical methodsVinicius Viana Abreu Montanaro, Mina Jacob, Kay Sin Tan, et al.
The New England Journal of Medicine|December 22, 2018
Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016, Valery L Feigin, Grant Nguyen, et al.
Lancet (London, England)|September 1, 2015
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition, Christopher J L Murray, Ryan M Barber, et al.
Pageof 22

Showing results (201-210 of 211) with videos related to

Sort By:
Pageof 22
European Stroke Journal|August 20, 2021
Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) - study protocol for a randomised controlled trialPeter Kelly, Christian Weimar, Robin Lemmens, et al.
Journal of Neuroimmunology|August 6, 2014
Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: a systematic review and meta-analysisAlejandro Bustamante, Tomás Sobrino, Dolors Giralt, et al.
The New England Journal of Medicine|February 18, 2016
Pioglitazone after Ischemic Stroke or Transient Ischemic AttackWalter N Kernan, Catherine M Viscoli, Karen L Furie, et al.
The New England Journal of Medicine|May 15, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral HemorrhageStuart J Connolly, Mukul Sharma, Alexander T Cohen, et al.
The Lancet. Neurology|December 15, 2023
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trialMukul Sharma, Carlos A Molina, Kazunori Toyoda, et al.
BMJ Open|November 16, 2019
Global Outcome Assessment Life-long after stroke in young adults initiative-the GOAL initiative: study protocol and rationale of a multicentre retrospective individual patient data meta-analysisMerel S Ekker, Mina A Jacob, Myrna M E van Dongen, et al.
Neurology|December 15, 2021
Global Differences in Risk Factors, Etiology, and Outcome of Ischemic Stroke in Young Adults-A Worldwide Meta-analysis: The GOAL InitiativeMina A Jacob, Merel S Ekker, Youssra Allach, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 25, 2026
Prediction of recurrence and functional status in young ischemic stroke patients: Comparison of machine learning and traditional statistical methodsVinicius Viana Abreu Montanaro, Mina Jacob, Kay Sin Tan, et al.
The New England Journal of Medicine|December 22, 2018
Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016, Valery L Feigin, Grant Nguyen, et al.
Lancet (London, England)|September 1, 2015
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition, Christopher J L Murray, Ryan M Barber, et al.
Pageof 22